Prognostic impact of intrahepatic lymphatic and microvascular involvement in cases of colorectal liver metastases

Int J Colorectal Dis. 2009 Jul;24(7):845-50. doi: 10.1007/s00384-009-0674-6. Epub 2009 Feb 25.

Abstract

Objective: The purpose of this study was to evaluate the effect of intrahepatic microvascular and lymphatic infiltration on survival in cases of colorectal liver metastases.

Materials and methods: Prospectively collected data of 331 patients were analyzed for microvascular invasion (V), lymphatic infiltration (L), and resection margins (R) with respect to overall and disease-free survival.

Results: One-, 3-, and 5-year overall survival rates for R0 resected patients were 89%, 64%, and 39%, respectively. The corresponding survival rates for R1 resected patients were 83%, 42%, and 24% (p < 0.001). The sole presence of microvascular invasion (V1) or lymphatic infiltration (L1) was not associated with a diminished overall survival (p > 0.05). However, patients with a combination of L1V1 had a significantly worse overall survival of 68%, 20%, and 0% when compared to L0V0 patients. This difference was not influenced by the status of the resection margin. No other parameter investigated was found to be of predictive value.

Conclusions: The presence of combined lymphatic and vascular invasion (L1V1) constitutes a predictor of poor overall and disease-free survival. This subgroup of patients might benefit from adjuvant strategies such as chemotherapeutic treatment.

Publication types

  • Clinical Trial

MeSH terms

  • Colorectal Neoplasms / pathology*
  • Disease-Free Survival
  • Humans
  • Liver Neoplasms / drug therapy
  • Liver Neoplasms / mortality
  • Liver Neoplasms / secondary*
  • Liver Neoplasms / surgery
  • Lymphatic System / pathology*
  • Microvessels / pathology*
  • Middle Aged
  • Neoadjuvant Therapy
  • Perioperative Care
  • Prognosis
  • Treatment Outcome